‘Superpotent’ thyroid medication recalled one month after FDA advises against similar tablets
See more of our coverage in your search results. Vitruvias Therapeutics is recalling one lot of thyroid medication distributed nationwide after testing found the tablets could be more potent than intended, according to a recall notice published by the U.S. Food and Drug Administration (FDA). The Auburn, Alabama-based company voluntarily recalled Lot 504950 of Thyroid…
